PL310439A1 - Application of derivatives of 2-h-1,2,4-benzothiazin-3/4h/-one 1,1-dioxide as noncompetitive antagonists of nmda receptor - Google Patents

Application of derivatives of 2-h-1,2,4-benzothiazin-3/4h/-one 1,1-dioxide as noncompetitive antagonists of nmda receptor

Info

Publication number
PL310439A1
PL310439A1 PL94310439A PL31043994A PL310439A1 PL 310439 A1 PL310439 A1 PL 310439A1 PL 94310439 A PL94310439 A PL 94310439A PL 31043994 A PL31043994 A PL 31043994A PL 310439 A1 PL310439 A1 PL 310439A1
Authority
PL
Poland
Prior art keywords
benzothiazin
dioxide
derivatives
application
nmda receptor
Prior art date
Application number
PL94310439A
Other languages
English (en)
Inventor
Francois Audiau
Patrick Jimonet
Serge Mignani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of PL310439A1 publication Critical patent/PL310439A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
PL94310439A 1993-03-03 1994-02-25 Application of derivatives of 2-h-1,2,4-benzothiazin-3/4h/-one 1,1-dioxide as noncompetitive antagonists of nmda receptor PL310439A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9302439A FR2702150B1 (fr) 1993-03-03 1993-03-03 Application de dérivés de 2H-1,2-4-benzothiadiazine-3(4H)-one-1,1-dioxyde comme antagonistes non compétitifs du récepteur NMDA.
PCT/FR1994/000207 WO1994020109A1 (fr) 1993-03-03 1994-02-25 Application de derives de 2h-1,2,4-benzothiadiazine-3(4h)-one-1,1-dioxyde comme antagonistes non competitifs du recepteur nmda

Publications (1)

Publication Number Publication Date
PL310439A1 true PL310439A1 (en) 1995-12-11

Family

ID=9444603

Family Applications (1)

Application Number Title Priority Date Filing Date
PL94310439A PL310439A1 (en) 1993-03-03 1994-02-25 Application of derivatives of 2-h-1,2,4-benzothiazin-3/4h/-one 1,1-dioxide as noncompetitive antagonists of nmda receptor

Country Status (10)

Country Link
EP (1) EP0687178A1 (no)
JP (1) JPH08507303A (no)
AU (1) AU6143694A (no)
CA (1) CA2153951A1 (no)
FR (1) FR2702150B1 (no)
HU (1) HU9502572D0 (no)
IL (1) IL108784A0 (no)
NO (1) NO953387L (no)
PL (1) PL310439A1 (no)
WO (1) WO1994020109A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
EP2117540A1 (en) 2007-03-01 2009-11-18 Probiodrug AG New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
SG178953A1 (en) 2009-09-11 2012-04-27 Probiodrug Ag Heterocylcic derivatives as inhibitors of glutaminyl cyclase
US9181233B2 (en) 2010-03-03 2015-11-10 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2011226074B2 (en) 2010-03-10 2015-01-22 Vivoryon Therapeutics N.V. Heterocyclic inhibitors of glutaminyl cyclase (QC, EC 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
ES2570167T3 (es) 2011-03-16 2016-05-17 Probiodrug Ag Derivados de benzimidazol como inhibidores de glutaminil ciclasa
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB975925A (en) * 1961-02-21 1964-11-25 Scherico Ltd 3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxides
US4716161A (en) * 1984-04-17 1987-12-29 Mitsubishi Chemical Industries Limited Phenylpiperazine derivatives and their acid addition salts
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
FR2690160A1 (fr) * 1992-04-15 1993-10-22 Rhone Poulenc Rorer Sa Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant.
AU3957093A (en) * 1992-04-15 1993-11-18 Rhone-Poulenc Rorer S.A. 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same

Also Published As

Publication number Publication date
FR2702150B1 (fr) 1995-04-07
EP0687178A1 (fr) 1995-12-20
WO1994020109A1 (fr) 1994-09-15
CA2153951A1 (fr) 1994-09-15
AU6143694A (en) 1994-09-26
JPH08507303A (ja) 1996-08-06
NO953387D0 (no) 1995-08-29
IL108784A0 (en) 1994-06-24
FR2702150A1 (fr) 1994-09-09
HU9502572D0 (en) 1995-11-28
NO953387L (no) 1995-08-29

Similar Documents

Publication Publication Date Title
ZA903020B (en) Piperazine derivatives
EP0442878A4 (en) Derivatives of tryptophan as cck antagonists
PH30439A (en) 3,4-Dihydro-2h-1,4-benz-oxazine derivatives and pharmaceutical compositions containing the same
GR900100516A (en) Cck analogous amino-acid antagonists
EP0488959A3 (en) New uses of competitive nmda receptor antagonists
PL310439A1 (en) Application of derivatives of 2-h-1,2,4-benzothiazin-3/4h/-one 1,1-dioxide as noncompetitive antagonists of nmda receptor
GB9217475D0 (en) Nauroprotective use cck antagonists
HU9600124D0 (en) 1,5-benzodiazepine derivatives useful as cck or gastrin antagonists
EP0434827A4 (en) Quinolinyl-benzopyran derivatives as antagonists of leukotriene d 4?
AU4282993A (en) Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists
GB2239239B (en) 3-(n-methyl-n-alkylamino)-2-methoxymethyl-propanol derivatives
ZA894097B (en) Alpha-adrenergic receptor antagonists
GB2234508B (en) Dihydropyrimido(2,1-b)(1,3) thiazine derivatives
NZ300041A (en) 2-(2,3,5,6-tetrafluoropyridin-4-yl)-1,2,5-thiazolidin-3-one 1,1-dioxide derivatives
GB2231051B (en) Bombesin antagonists
GB2270313B (en) 1,3,4-Benzotriazepin-5 (4H)-one derivatives and process for the preparation thereof
OA09328A (en) "Heterocyclic compounds".
ZA90301B (en) 8,9-annelated-1,2,3,4-tetrahydro-beta-carboline derivatives
RU2094435C1 (en) 7-oxo-1-azabicyclo-(3,2,0) hept-2-ene derivatives and intermediate compounds for preparation thereof
GB8902573D0 (en) Heterocyclic derivatives
ZA906684B (en) Heterocyclic derivatives
ZA904621B (en) New thioformamide derivatives
GB8921077D0 (en) Thiazepine derivatives
ZA903369B (en) Thiazepine derivatives
IE894229L (en) Thiazole derivatives